These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6076509)
61. Evaluation of a new selective beta-adrenergic receptor stimulant. Chervinsky P Ann Allergy; 1971 Dec; 29(12):627-30. PubMed ID: 4942442 [No Abstract] [Full Text] [Related]
62. A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma. Crompton GK Thorax; 1968 Jan; 23(1):46-55. PubMed ID: 5637498 [TBL] [Abstract][Full Text] [Related]
64. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine. Muittari A; Mattila MJ; Tiitinen H Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181 [No Abstract] [Full Text] [Related]
65. Controlled trial of metaproterenol aerosol inbronchial asthma. Coleman ME; Howard LA Ann Allergy; 1965 Sep; 23(9):434-6. PubMed ID: 5318773 [No Abstract] [Full Text] [Related]
66. Airway resistance as an index of effectiveness of bronchodilating drugs. Feinsilver O J Allergy; 1966 Oct; 38(4):195-207. PubMed ID: 5332397 [No Abstract] [Full Text] [Related]
67. Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach. Kelsen SG; Kelsen DP; Fleeger BF; Jones RC; Rodman T Am J Med; 1978 Apr; 64(4):622-8. PubMed ID: 645728 [No Abstract] [Full Text] [Related]
68. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Choo-Kang YF; Simpson WT; Grant IW Br Med J; 1969 May; 2(5652):287-9. PubMed ID: 4888877 [TBL] [Abstract][Full Text] [Related]
69. Oral orciprenaline in the treatment of chronic asthma. Rebuck AS; Read J Med J Aust; 1969 Mar; 1(9):445-6. PubMed ID: 4976173 [No Abstract] [Full Text] [Related]
71. A comparison of the cardiorespiratory effects of salbutamol and isoproterenol-phenylephrine aerosols in asthma. Riding WD; Chatterjee SS; Bernstein A; Dinda P Am Rev Respir Dis; 1971 Nov; 104(5):688-93. PubMed ID: 4399429 [No Abstract] [Full Text] [Related]
75. The treatment of bronchial asthma. Grant IW BTTA Rev; 1971 Dec; 1(4):43-52. PubMed ID: 4338363 [No Abstract] [Full Text] [Related]
76. [Study of the bronchodilator effect of a new sympathomimetic preparation in measured aerosols]. Charpin J; Grimaud C; Ohresser P; Boutin C; Aubert J; Casanova P Mars Med; 1967; 104(6):585-8. PubMed ID: 5618406 [No Abstract] [Full Text] [Related]
77. Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance. Bäcklund L; Fagerberg E Scand J Respir Dis; 1968; 49(4):284-90. PubMed ID: 5194717 [No Abstract] [Full Text] [Related]
78. Localization of the bronchodilatory effects of isoproterenol and aminophylline in patients with bronchial asthma: an investigation using selective alveolobronchography. Murata T; Imamura M; Taniguchi M; Tanaka Y J Int Med Res; 1997; 25(6):325-39. PubMed ID: 9427166 [TBL] [Abstract][Full Text] [Related]
79. Assessment of orciprenaline and isoproterenol infusions in asthmatic patients. McEvoy JD; Vall-Spinosa A; Paterson JW Am Rev Respir Dis; 1973 Sep; 108(3):490-500. PubMed ID: 4745246 [No Abstract] [Full Text] [Related]
80. [Value of a new sympathomimetic in infantile respiratory diseases]. Vialatte J Sem Ther; 1966 Oct; 42(8):428-30. PubMed ID: 5994380 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]